MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)
source: myfinsight.com
Download
Download image
Proceeds from avenue
capital loan agreement
$6,716,561
Cash receipt from
stock subscription...
$1,070,000
Net cash provided by
financing activities
$7,786,561
Net increase
(decrease) in cash and cash...
$6,141,527
Canceled cashflow
$1,645,034
Amortization of deferred
offering cost
$477,647
Stock-based compensation
expense
$280,830
Net cash used in
operating activities
-$1,632,807
Net cash used in
investing activities
-$12,227
Canceled cashflow
$758,477
Net loss
-$970,972
Net gain from change
in fair value of...
$697,561
Purchases of intangible
assets
$12,227
Accounts payable and
accrued expenses
-$613,464
Prepaids and other
current assets
$123,738
Back